NACDS joins advocacy, other healthcare groups in battle against prescription drug diversion, abuse
ALEXANDRIA, Va. — The National Association of Chain Drug Stores announced that it has joined pain care advocacy and other healthcare organizations in urging members of Congress to help address the problem of prescription drug diversion and abuse.
In a letter to the U.S. Senate Health, Education, Labor and Pensions Committee; U.S. Judiciary Committee; U.S. House Committee on Judiciary; and the U.S. House Energy and Commerce Committee, the organizations urged Congress to create a commission or advisory group to bring together all government agency stakeholders to address the problem.
The groups wrote, “[We] are committed to partnering with law enforcement agencies, policy-makers and others to work on viable strategies to solve the problems of prescription drug diversion and abuse. Although numerous groups and state and federal entities are working to reduce these problems, success remains difficult to achieve. One challenge is that many of these groups and entities are not working in a coordinated manner.”
The letter emphasized the importance of reducing prescription drug diversion and abuse without negatively impacting legitimate patient access and care.
“While appropriate policies must empower law enforcement officials to act aggressively against individuals and entities actually engaging in diversion or abuse, diversion/abuse control actions must be balanced against the needs of healthcare providers to provide care to legitimate patients. We must ensure that legitimate patients receive critical medicines without interruption,” the groups stated in the letter.
In addition to NACDS, the following organizations signed the letter: American Academy of Pain Management; American Society for Pain Management Nursing; Center for Practical Bioethics; Inflexxion; International Nurses Society on Addictions; National Association of Directors of Nursing Administration in Long Term Care; National Fibromyalgia & Chronic Pain Association; Pain Treatment Topics; Purdue Pharma L.P.; U.S. Pain Foundation; and the Virginia Cancer Pain Initiative.
“Due to the urgent nature of the problems associated with prescription drug diversion and abuse, the advisory group’s recommendations should be provided to Congress within one year of its creation or enactment,” the groups concluded in the letter.
No comments found
Mr. Clean celebrates milestone as it produces its 1 billionth Magic Eraser
CINCINATTI – Procter & Gamble’s Mr. Clean brand on Friday announced that is has manufactured 1 billion Mr. Clean Magic Erasers since the product’s launch in 2003.
"Mr. Clean Magic Eraser is a remarkable product, and we are extremely proud to reach this landmark for the history of the brand," said Mr. Clean communications manager Michelle Lohman. "We are excited that in nine years, it has become a cleaning staple among our fans."
The water-activated micro-scrubbers of the Mr. Clean Magic Erasers reach into surface grooves, lifting away tough soils with only water. The Mr. Clean Magic Eraser can be used for removing scuff marks and dirt, cleaning grimy bathroom floors and removing stains from furniture and wooden decks.
The Mr. Clean Magic Eraser product lineup includes Extra Power, Bath Scrubber and Kitchen Scrubber versions for more specific uses, and is available in six multi-sized erasers.
No comments found
Rite Aid rolls out Diabetes Control Program in Cleveland
CLEVELAND — People with diabetes in Cleveland enrolled in UnitedHealthcare employer-sponsored health plans can obtain free diabetes management services from Rite Aid, the retail pharmacy chain said Friday.
The chain’s pharmacists are participating in the Diabetes Control Program, part of UnitedHealth Group’s Diabetes Prevention and Control Alliance, which is aimed at addressing the problem of Type 2 diabetes and prediabetes.
The program is available at 25 Rite Aid stores in the city, allowing people with the condition enrolled in it to connect with pharmacists trained in diabetes care and medication therapy management and receive private, one-on-one consultations that provide education and support.
Rite Aid began offering similar services as part of the Diabetes Control Program at 27 of its stores to residents of Long Island, N.Y., last month.
Competition for the diabetic patient at the retail pharmacy level is heating up.